Description
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Cas No. | 1638286-64-2 |
|---|---|
| Purity | ≥95% |
| Formula | C40H49NO12 |
| Formula Wt. | 735.83 |
| Synonym | De-boc-Cabazitaxel |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Thiol derivative, antioxidant.
TRPV4 agonist
Benzisoxazole; 5-HT7 and NMDA agonist, D-amino ...
Benzimidazole; microtubule polymerization inhib...
Synthetic steroid hormone, estrogen analog, use...
Benzamide; HDAC1 inhibitor.
Thiazide diuretic; NCCT inhibitor, carbonic anh...
Fluoroquinolone; topoisomerase IV and bacterial...
Cationic lipid polypeptide, mixture of polymyxi...
ATR inhibitor.
Thrombin substrate used to measure thrombin act...
Nicotinic acid derivative; InhA inhibitor.
Anthraquinone found in various plant sources; C...
Allylbenzene found in spices and umbelliferous ...
Endogenous cardiomodulatory peptide; NPR-A agon...
Fatty acid synthase inhibitor.
Inhibitor of VEGFR1/2/3.
Selective cannabinoid receptor 2 (CB2) inverse ...
Endogenous peptide, involved in hormone regulat...
Endogenous peptide fragment, immunostimulant; ...